# Mesenchymal Stem Cell Administration in the Treatment of Coronary Graft Disease in Heart Transplant Patients

> **NCT02472002** · PHASE1,PHASE2 · SUSPENDED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 14 (estimated)

## Conditions studied

- Coronary Disease
- Heart Transplant

## Interventions

- **BIOLOGICAL:** Mesenchymal cell therapy

## Key facts

- **NCT ID:** NCT02472002
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2014-01
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 14 (ESTIMATED)
- **Why stopped:** Contamination of the Pitié-Salpêtrière biotherapy laboratory
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02472002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02472002, "Mesenchymal Stem Cell Administration in the Treatment of Coronary Graft Disease in Heart Transplant Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02472002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*